These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3207935)

  • 21. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria.
    Kosten TA; Jacobsen LK; Kosten TR
    Am J Drug Alcohol Abuse; 1989; 15(3):237-50. PubMed ID: 2763981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003.
    Barbosa-Leiker C; McPherson S; Mamey MR; Burns GL; Layton ME; Roll J; Ling W
    Drug Alcohol Depend; 2015 Jul; 152():218-23. PubMed ID: 25908321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic.
    Gold MS; Pottash AL; Sweeney DR; Davies RK; Kleber HD
    Subst Alcohol Actions Misuse; 1980; 1(2):239-46. PubMed ID: 7302782
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of naloxone in the assessment of opiate dependence.
    Fudala PJ; Berkow LC; Fralich JL; Johnson RE
    Life Sci; 1991; 49(24):1809-14. PubMed ID: 1943484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A general theory of addiction to opiate-type drugs.
    Lindesmith AR
    NIDA Res Monogr; 1980 Mar; 30():34-7. PubMed ID: 6779192
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.
    Harris AC; Gewirtz JC
    Psychopharmacology (Berl); 2005 Apr; 178(4):353-66. PubMed ID: 15696323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retracted confessions: through opiate withdrawal to a new conceptual framework.
    Davison SE; Forshaw DM
    Med Sci Law; 1993 Oct; 33(4):285-90. PubMed ID: 8264359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological correlates of opioid dependence and withdrawal.
    Lyvers M; Yakimoff M
    Addict Behav; 2003 Apr; 28(3):605-11. PubMed ID: 12628632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case report of propofol dependence in a physician.
    Bonnet U; Harkener J; Scherbaum N
    J Psychoactive Drugs; 2008 Jun; 40(2):215-7. PubMed ID: 18720673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of physical and psychological dependence on butorphanol.
    Harshe DG; Mate OS; Cholera RM; Kale S
    J Opioid Manag; 2015; 11(2):112-3. PubMed ID: 26035913
    [No Abstract]   [Full Text] [Related]  

  • 31. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 32. [Symptoms of hallucinogen and opiate use and withdrawal syndrome].
    Ladewig D
    Wien Med Wochenschr; 1981 Mar; 131(5):115-8. PubMed ID: 7233905
    [No Abstract]   [Full Text] [Related]  

  • 33. Opiate withdrawal: the result of conditioning or physiological mechanisms?
    Zellner DA; Dacanay RJ; Riley AL
    Pharmacol Biochem Behav; 1984 Feb; 20(2):175-80. PubMed ID: 6538972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat.
    Malin DH; Henceroth MM; Elayoubi J; Campbell JR; Anderson A; Goyarzu P; Izygon J; Madison CA; Ward CP; Burstein ES
    Neurosci Lett; 2018 Sep; 684():98-103. PubMed ID: 29981879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C; Blyth A; Maskrey V; Pinto H; Holland R
    Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component.
    Schuckit MA; Daeppen JB; Danko GP; Tripp ML; Smith TL; Li TK; Hesselbrock VM; Bucholz KK
    Am J Psychiatry; 1999 Jan; 156(1):41-9. PubMed ID: 9892296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of withdrawal jumping: comparison of narcotic tolerance and dependence.
    Masten LW; Way EL
    Drug Alcohol Depend; 1980 Jun; 5(6):401-9. PubMed ID: 7189707
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropsychological deficits and opiate abuse.
    Davis PE; Liddiard H; McMillan TM
    Drug Alcohol Depend; 2002 Jun; 67(1):105-8. PubMed ID: 12062785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.